Drug safety

Keyphrases

Publications

volume 47, number 7, 2024

Bereket Tesfaldet, Tejas Patel, Minjun Chen, Frank Pucino, Lilliam Rosario, Paul Hayashi, Eileen Navarro Almario
Composite Plot for Visualizing Aminotransferase and Bilirubin Changes in Clinical Trials of Subjects with Abnormal Baseline Values. Drug safety 47 (7) (2024)
Bereket Tesfaldet, Tejas Patel, Minjun Chen, Frank Pucino, Lilliam Rosario, Paul Hayashi, Eileen Navarro Almario
Composite Plot for Visualizing Aminotransferase and Bilirubin Changes in Clinical Trials of Subjects with Abnormal Baseline Values. Drug safety 47 (7) (2024)
Brandon W Lennep, Jesse Mack, Srinivasu Poondru, Elizabeth Hood, Brooke D Looney, Monique Williams, Judeth J Bianco, Alicia K Morgans
Enzalutamide: Understanding and Managing Drug Interactions to Improve Patient Safety and Drug Efficacy. Drug safety 47 (7) (2024)
Bereket Tesfaldet, Tejas Patel, Minjun Chen, Frank Pucino, Lilliam Rosario, Paul Hayashi, Eileen Navarro Almario
Composite Plot for Visualizing Aminotransferase and Bilirubin Changes in Clinical Trials of Subjects with Abnormal Baseline Values. Drug safety 47 (7) (2024)
Meredith Y Smith, Elaine H Morrato, Nallely Mora, Viviana Nguyen, Hilary Pinnock, Almut G Winterstein
The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE). Drug safety 47 (7) (2024)
Hyunjoo Kim, Nayeong Son, Dahee Jeong, Myungsik Yoo, In Young Choi, Wona Choi, Yeon Woong Chung, Sung Woo Ko, Seonjeong Byun, Sun Im, Da Woon Sim, Jewon Seo, Min-Gyu Kang, Jun Kyu Lee, Young-Gyun Seo, Hye-Ji An, Yeesuk Kim, Sungeu Chae, Dae Won Jun, Dong-Jin Chang, Seong Geun Kim, Siyeon Yi, Hyeon-Jong Yang, Inho Lee, Hye Jung Park, Jae-Hyun Lee, Bong Gi Kim, Eunkyung Euni Lee
Angiotensin Receptor Blockers and the Risk of Suspected Drug-Induced Liver Injury: A Retrospective Cohort Study Using Electronic Health Record-Based Common Data Model in South Korea. Drug safety 47 (7) (2024)
Ying Li, Lin Dang, Chengzhi Lv, Bingjiang Lin, Juan Tao, Nan Yu, Ya Deng, Huiping Wang, Xiaojing Kang, Hui Qin, Rong Chen, Jinnan Li, Yunsheng Liang, Yanhua Liang, Yu-Ling Shi
The Safety of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: Analyses from a Prospective, Single-Arm, Multicenter, 12-Week Observational Study. Drug safety 47 (7) (2024)
Maria Gordillo-Marañón, Gianmario Candore, Karin Hedenmalm, Kate Browne, Robert Flynn, Loris Piccolo, Aniello Santoro, Cosimo Zaccaria, Xavier Kurz
Lessons Learned on Observed-to-Expected Analysis Using Spontaneous Reports During Mass Vaccination. Drug safety 47 (7) (2024)
Brandon W Lennep, Jesse Mack, Srinivasu Poondru, Elizabeth Hood, Brooke D Looney, Monique Williams, Judeth J Bianco, Alicia K Morgans
Enzalutamide: Understanding and Managing Drug Interactions to Improve Patient Safety and Drug Efficacy. Drug safety 47 (7) (2024)
Bereket Tesfaldet, Tejas Patel, Minjun Chen, Frank Pucino, Lilliam Rosario, Paul Hayashi, Eileen Navarro Almario
Composite Plot for Visualizing Aminotransferase and Bilirubin Changes in Clinical Trials of Subjects with Abnormal Baseline Values. Drug safety 47 (7) (2024)

volume 47, number 8, 2024

Rita A Baião, Raquel Vareda, Andreia Lopes
Comment on: "Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: A Swedish Population-Based Cohort Study". Drug safety 47 (8) (2024)
Maria Gordillo-Marañón, Agnieszka Szmigiel, Vladimíra Yalmanová, Irina Caplanusi, Georgy Genov, David Benee Olsen, Sabine Straus
COVID-19 Vaccines and Heavy Menstrual Bleeding: The Impact of Media Attention on Reporting to EudraVigilance. Drug safety 47 (8) (2024)
Renato de Filippis, John M Kane, Elena Arzenton, Ugo Moretti, Emanuel Raschi, Gianluca Trifirò, Corrado Barbui, Cristina Segura-Garcia, Chiara Gastaldon, Georgios Schoretsanitis
Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database. Drug safety 47 (8) (2024)
Joanne Treacy, Elaine H Morrato, Robert Horne, Michael S Wolf, Ameet Bakhai, Marie-Claire Wilson, Mark Lightowler, Sibel Guerler, Jeremy D Jokinen
Behavioral Science: Enhancing Our Approach to the Development of Effective Additional Risk Minimization Strategies. Drug safety 47 (8) (2024)
Anum Saqib Zaidi, Gregory Mark Peterson, Colin M Curtain, Mohammed Saji Salahudeen
Predictors of Adverse Drug Reaction-Related Hospitalisations Among People with Dementia: A Retrospective Case-Control Study. Drug safety 47 (8) (2024)
Nele Brusselaers
Author's Reply to Avó-Baião et al.'s Comment on "Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: A Swedish Population-Based Cohort Study". Drug safety 47 (8) (2024)
Renato de Filippis, John M Kane, Elena Arzenton, Ugo Moretti, Emanuel Raschi, Gianluca Trifirò, Corrado Barbui, Cristina Segura-Garcia, Chiara Gastaldon, Georgios Schoretsanitis
Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database. Drug safety 47 (8) (2024)
Maria Gordillo-Marañón, Agnieszka Szmigiel, Vladimíra Yalmanová, Irina Caplanusi, Georgy Genov, David Benee Olsen, Sabine Straus
COVID-19 Vaccines and Heavy Menstrual Bleeding: The Impact of Media Attention on Reporting to EudraVigilance. Drug safety 47 (8) (2024)
Anum Saqib Zaidi, Gregory Mark Peterson, Colin M Curtain, Mohammed Saji Salahudeen
Predictors of Adverse Drug Reaction-Related Hospitalisations Among People with Dementia: A Retrospective Case-Control Study. Drug safety 47 (8) (2024)
Christopher A Gravel, William Bai, Antonios Douros
Comparators in Pharmacovigilance: A Quasi-Quantification Bias Analysis. Drug safety 47 (8) (2024)
Anum Saqib Zaidi, Gregory Mark Peterson, Colin M Curtain, Mohammed Saji Salahudeen
Predictors of Adverse Drug Reaction-Related Hospitalisations Among People with Dementia: A Retrospective Case-Control Study. Drug safety 47 (8) (2024)
Maria Gordillo-Marañón, Agnieszka Szmigiel, Vladimíra Yalmanová, Irina Caplanusi, Georgy Genov, David Benee Olsen, Sabine Straus
COVID-19 Vaccines and Heavy Menstrual Bleeding: The Impact of Media Attention on Reporting to EudraVigilance. Drug safety 47 (8) (2024)
Carina D'Aiuto, Carlotta Lunghi, Line Guénette, Djamal Berbiche, Karine Bertrand, Helen-Maria Vasiliadis
Risk of Mortality Associated with Potentially Inappropriate Medication Use Including Opioids in Older Adults. Drug safety 47 (8) (2024)
Maria Gordillo-Marañón, Agnieszka Szmigiel, Vladimíra Yalmanová, Irina Caplanusi, Georgy Genov, David Benee Olsen, Sabine Straus
COVID-19 Vaccines and Heavy Menstrual Bleeding: The Impact of Media Attention on Reporting to EudraVigilance. Drug safety 47 (8) (2024)
Christopher A Gravel, William Bai, Antonios Douros
Comparators in Pharmacovigilance: A Quasi-Quantification Bias Analysis. Drug safety 47 (8) (2024)
Christopher A Gravel, William Bai, Antonios Douros
Comparators in Pharmacovigilance: A Quasi-Quantification Bias Analysis. Drug safety 47 (8) (2024)
Robin E Ferner, Jeffrey K Aronson
Competing Benefits and Competing Hazards: The Benefit to Harm Balance in Individual Patients in Rational Therapeutics. Drug safety 47 (8) (2024)
Samantha B Shapiro, Hui Yin, Oriana H Y Yu, Laurent Azoulay
Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort Study. Drug safety 47 (8) (2024)
Renato de Filippis, John M Kane, Elena Arzenton, Ugo Moretti, Emanuel Raschi, Gianluca Trifirò, Corrado Barbui, Cristina Segura-Garcia, Chiara Gastaldon, Georgios Schoretsanitis
Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database. Drug safety 47 (8) (2024)

volume 47, number 9, 2024

Diego F Wyszynski, Lydia Demetriou, Cheryl Renz, Shirin Aliabadi, Dragutin Rafailovic, Lee P Shulman, Myriam Drysdale, Keele E Wurst
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry. Drug safety 47 (9) (2024)
Mufaddal Mahesri, Ameet Sarpatwari, Krista F Huybrechts, Joyce Lii, Su Been Lee, Gita A Toyserkani, Cynthia LaCivita, Esther H Zhou, Gerald J Dal Pan, Aaron S Kesselheim, Katsiaryna Bykov
Trends in Use and Evidence of Adherence to Risk Evaluation and Mitigation Strategy Pregnancy Testing Requirements for Thalidomide, Lenalidomide, and Pomalidomide in the USA, 2000-2020. Drug safety 47 (9) (2024)
Rebeccah Nehard, Catherine Vauzelle, Delphine Beghin, Mathilde Latour, Elisabeth Elefant, Bénédicte Coulm, Benoît Marin
Post-Conceptional Exposure to Clomiphene Citrate and Congenital Malformations: A Cohort Study. Drug safety 47 (9) (2024)
Tiphaine Pierson, Verna Arcand, Barbara Farrell, Camille L Gagnon, Larry Leung, Lisa M McCarthy, Andrea L Murphy, Nav Persaud, Lalitha Raman-Wilms, James L Silvius, Michael A Steinman, Cara Tannenbaum, Wade Thompson, Johanna Trimble, Cheryl A Sadowski, Emily G McDonald
Proceedings of the Canadian Medication Appropriateness and Deprescribing Network's 2023 National Meeting. Drug safety 47 (9) (2024)
Diego F Wyszynski, Lydia Demetriou, Cheryl Renz, Shirin Aliabadi, Dragutin Rafailovic, Lee P Shulman, Myriam Drysdale, Keele E Wurst
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry. Drug safety 47 (9) (2024)
Adi Mor, Scott Friedman, Sharon Hashmueli, Amnon Peled, Massimo Pinzani, Matthew Frankel, Rifaat Safadi
Targeting CCL24 in Inflammatory and Fibrotic Diseases: Rationale and Results from Three CM-101 Phase 1 Studies. Drug safety 47 (9) (2024)
Diego F Wyszynski, Lydia Demetriou, Cheryl Renz, Shirin Aliabadi, Dragutin Rafailovic, Lee P Shulman, Myriam Drysdale, Keele E Wurst
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry. Drug safety 47 (9) (2024)
Adi Mor, Scott Friedman, Sharon Hashmueli, Amnon Peled, Massimo Pinzani, Matthew Frankel, Rifaat Safadi
Targeting CCL24 in Inflammatory and Fibrotic Diseases: Rationale and Results from Three CM-101 Phase 1 Studies. Drug safety 47 (9) (2024)
Arianna Simonetti, Susan Colilla, Brian D Edwards, Jürgen Kübler, Leila Lackey, Lisa Rodriguez, Susan Talbot, Hong Yang, William Wang, Danae Williams, James Matthew Higginson
Key Opinion Leaders' Interviews to Inform the Future of Benefit-Risk Planning in the Medical Total Product Life Cycle of Global Pharmaceutical and Medical Device Organizations. Drug safety 47 (9) (2024)
Tiphaine Pierson, Verna Arcand, Barbara Farrell, Camille L Gagnon, Larry Leung, Lisa M McCarthy, Andrea L Murphy, Nav Persaud, Lalitha Raman-Wilms, James L Silvius, Michael A Steinman, Cara Tannenbaum, Wade Thompson, Johanna Trimble, Cheryl A Sadowski, Emily G McDonald
Proceedings of the Canadian Medication Appropriateness and Deprescribing Network's 2023 National Meeting. Drug safety 47 (9) (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety 47 (9) (2024)
Adi Mor, Scott Friedman, Sharon Hashmueli, Amnon Peled, Massimo Pinzani, Matthew Frankel, Rifaat Safadi
Targeting CCL24 in Inflammatory and Fibrotic Diseases: Rationale and Results from Three CM-101 Phase 1 Studies. Drug safety 47 (9) (2024)
Antoine Pariente, Francesco Salvo, Virginie Bres, Jean-Luc Faillie
Can We Ask ChatGPT About Drug Safety? Appropriateness of ChatGPT Responses to Questions About Drug Use and Adverse Reactions Received by Pharmacovigilance Centers. Drug safety 47 (9) (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety 47 (9) (2024)
Arianna Simonetti, Susan Colilla, Brian D Edwards, Jürgen Kübler, Leila Lackey, Lisa Rodriguez, Susan Talbot, Hong Yang, William Wang, Danae Williams, James Matthew Higginson
Key Opinion Leaders' Interviews to Inform the Future of Benefit-Risk Planning in the Medical Total Product Life Cycle of Global Pharmaceutical and Medical Device Organizations. Drug safety 47 (9) (2024)
Mufaddal Mahesri, Ameet Sarpatwari, Krista F Huybrechts, Joyce Lii, Su Been Lee, Gita A Toyserkani, Cynthia LaCivita, Esther H Zhou, Gerald J Dal Pan, Aaron S Kesselheim, Katsiaryna Bykov
Trends in Use and Evidence of Adherence to Risk Evaluation and Mitigation Strategy Pregnancy Testing Requirements for Thalidomide, Lenalidomide, and Pomalidomide in the USA, 2000-2020. Drug safety 47 (9) (2024)
Tiphaine Pierson, Verna Arcand, Barbara Farrell, Camille L Gagnon, Larry Leung, Lisa M McCarthy, Andrea L Murphy, Nav Persaud, Lalitha Raman-Wilms, James L Silvius, Michael A Steinman, Cara Tannenbaum, Wade Thompson, Johanna Trimble, Cheryl A Sadowski, Emily G McDonald
Proceedings of the Canadian Medication Appropriateness and Deprescribing Network's 2023 National Meeting. Drug safety 47 (9) (2024)
Ursula Winterfeld
Bridging the Evidence Gap: Sotrovimab Use in Pregnancy and the Need for Comprehensive Drug Safety Data. Drug safety 47 (9) (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety 47 (9) (2024)
Mufaddal Mahesri, Ameet Sarpatwari, Krista F Huybrechts, Joyce Lii, Su Been Lee, Gita A Toyserkani, Cynthia LaCivita, Esther H Zhou, Gerald J Dal Pan, Aaron S Kesselheim, Katsiaryna Bykov
Trends in Use and Evidence of Adherence to Risk Evaluation and Mitigation Strategy Pregnancy Testing Requirements for Thalidomide, Lenalidomide, and Pomalidomide in the USA, 2000-2020. Drug safety 47 (9) (2024)
Arianna Simonetti, Susan Colilla, Brian D Edwards, Jürgen Kübler, Leila Lackey, Lisa Rodriguez, Susan Talbot, Hong Yang, William Wang, Danae Williams, James Matthew Higginson
Key Opinion Leaders' Interviews to Inform the Future of Benefit-Risk Planning in the Medical Total Product Life Cycle of Global Pharmaceutical and Medical Device Organizations. Drug safety 47 (9) (2024)